Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma

American Journal of Gastroenterology

Volumn 95, Issue 2, 2000, Pages 387-394

  Weston, Allan P ^a,b   Badr, Adnan S ^a,b   Topalovski, Margarita ^a,b   Cherian, Rachel ^a,b   Dixon, Anita ^a,b   Hassanein, Ruth S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; BARRETT ESOPHAGUS; BIOPSY; CHI-SQUARE DISTRIBUTION; COLORING AGENTS; ENZYME INHIBITORS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KANSAS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PROTON PUMPS; SMOKING; STOMACH DISEASES;

EID: 0033967016     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00817-5     Document Type: Article

References (91)

1. Schistosomes, liver flukes, and Helicobacter pylori. 61:1994;177-241 IARC, Lyon, France.
2. Loffeld R.J., Willems I., Flendrig J.A., et al. Helicobacter pylori and gastric carcinoma. Histopathology. 17:1990;537-541.
3. Parsonnet J., Vandersteen D.P., Goates J., et al. Helicobacter pylori in intestinal- and diffuse-type gastric adenocarcinoma. J Natl Cancer Inst. 83:1991;640-643.
4. Talley N.J., Zinsmeister A.R., Weaver A., et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 83:1991;1734-1739.
5. Forman D., Newell D.G., Fullerton F., et al. Association between infection with Helicobacter pylori and risk of gastric cancer. Evidence from a prospective investigation. Br Med J. 302:1991;1302-1305.
6. Parsonnet J., Friedman G.D., Vandersteen D.P., et al. Helicobacter pylori infection, and the risk of gastric carcinoma. N Engl J Med. 325:1991;1127-1131.
7. Nomura A., Stemmermann G.N., Chyou P.H., et al. Helicobacter pylori infection, and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 325:1991;1132-1136.
8. Dwyer B., Kaldor J., Tee W., et al. Antibody response to Campylobacter pylori in diverse ethnic groups. Scand J Infect Dis. 20:1988;349-350.
9. Megraud F., Brassens-Rabbe M.P., Denis F., et al. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol. 27:1989;1870-1873.
10. Perez-Perez G.I., Taylor D.N., Bodhidatta L., et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis. 161:1990;1237-1241.
11. Isaacson P.G., Norton A.J. Mucosa-associated lymphoid tissue (MALT) and the MALT lymphoma concept. Isaacson P.G., Norton A.J. Extranodal lymphomas. 1994;5-14 Churchill Livingstone, New York.
12. Isaacson P.G. Gastrointestinal lymphoma. Hum Pathol. 25:1994;1020-1029.
13. Sigal S.H., Saul S.H., Auerbach H.E., et al. Gastric small lymphocytic proliferation with immunoglobulin gene rearrangement in pseudolymphoma versus lymphoma. Gastroenterology. 97:1989;195-201.
14. Doglioni C., Wotherspoon A., Moschini A., et al. High incidence of primary gastric lymphoma in northeastern Italy. Lancet. 339:1992;834-835.
15. Isaacson P.G., Spencer J. Is gastric lymphoma an infectious disease? Hum Pathol. 24:1993;569-570.
16. Cameron A.J., Lomboy C.T., Pera M., et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology. 109:1995;1541-1546.
17. Spechler S.J., Goyal R.K. Barrett's esophagus. N Engl J Med. 315:1986;362-371.
18. Haggitt R.C., Dean P.J. Adenocarcinoma in Barrett's epithelium. Spechler S.J., Goyal R. Barrett's esophagus Pathophysiology, diagnosis, and management . 1985;53-166 Elsevier Science, New York.
19. Haggitt R.C., Tryzelaar J., Ellis F.H., et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol. 70:1978;1-5.
20. Naef Ap, Savary M., Ozzello L. Columnar-lined lower esophagus An acquired lesion with malignant predisposition . J Thorac Cardiovasc Surg. 70:1975;826-835.
21. Quddus M.R., Henley J.D., Sulaiman R.A., et al. Helicobacter pylori infection, and adenocarcinoma arising in Barrett's esophagus. Hum Pathol. 28:1997;1007-1009.
22. Torrado J., Ruiz B., Garay J., et al. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus. Am J Surg Pathol. 21:1997;1023-1029.
23. Wright T.A., Myskow M., Kingsnorth A.N. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Dis Esophagus. 10:1997;196-200.
24. + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 58:1998;588-590.
25. Schnell T.G., Sontag S.J., Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci. 37:1992;137-143.
26. Sharma P., Morales T.G., Smapliner R.E. Short segment Barrett's esophagus - the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 93:1998;1033-1036.
27. Weston A.P., Krmpotich P., Makdisi W.F., et al. Short segment Barrett's esophagus Clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia . Am J Gastroenterology. 91:1996;981-986.
28. Reid B.J., Weinstein W.M., Lewin K.J., et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology. 94:1988;81-90.
29. Hetzel D.J., Dent J., Reed W.D., et al. Healing and relapse of severe peptic esophagitis after treatment with omperazole. Gastroenterology. 95:1988;903-912.
30. Rubin C.E., Haggitt R.C., Levine D.S. Endoscopic mucosal biopsy. Yamada T., Alpers D.H., Owyang C., et al. Textbook of gastroenterology. 1991;2479-2523 Lippincott, Philadelphia.
31. Haggitt R.C., Rubin C.E. Endoscopy and endoscopic biopsy. Ming S.-C., Goldman H.E. Gastrointestinal pathology. 1992;37-47 Saunders, Philadelphia.
32. Haggitt R.C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 25:1994;982-993.
33. Gottfried M.R., McClave S.A., Boyce H.W. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus). Am J Clin Pathol. 92:1989;741-746.
34. Schmidt H.G., Riddell R.H., Walther B., et al. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol. 110:1985;145-152.
35. Riddell R.H., Goldman H., Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease Standardized classification with provisional clinical implications . Hum Pathol. 14:1983;931-968.
36. Blount P.L., Rabinovitch P.S., Reid B.J. DNA content flow cytometry and neoplastic progression in the gastrointestinal tract. Eastwood G.L. Premalignant conditions of the gastrointestinal tract Pathogenesis, diagnosis, and management . 1990;55-77 Elsevier Science, New York.
37. Reid B.J. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am. 20:1991;817-834.
38. Reid B.J., Haggitt R.C., Rubin R.C., et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol. 19:1988;166-178.
39. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gasritis The updated Sydney system . Am J Surg Pathol. 20:1996;1161-1181.
40. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287-1289.
41. Haggitt R.C. Adenocarcinoma in Barrett's Esophagus. A new epidemic? Hum Pathol. 23:1992;475-476.
42. Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 104:1993;510-513.
43. Parsonnet J. Incidence of Helicobacter pylori infection. Alimen Pharmacol Ther. 9:(suppl 2):1995;45-51.
44. + proportion of Helicobacter pylori infections. Int J Cancer. 72:1997;453-456.
45. Parsonnet J., Blaser M.J., Perez-Perez G.I., et al. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology. 102:1992;41-46.
46. Genta R.M., Graham D.Y. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori A topographic study of H. pylori density and distribution . Gastrointest Endosc. 40:1994;342-345.
47. Genta R.M. Pathology of Helicobacter pylori infection. Weinstein R.S. Advances in pathology and laboratory medicine. Volume 7. 1994;443-465 Mosby-Year Book, St Louis.
48. Barthel J.S., Everett E.D. Diagnosis of Campylobacter pylori infection The "gold standard" and the alternative . Rev Infect Dis. 12:(suppl 1):1990;S107-S114.
49. Brown K.E., Peura D.A. Diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am. 22:1993;105-115.
50. Schnell G.A., Schubert T.T. Usefulness of culture, histology, and urease testing in the detection of Campylobacter pylori. Am J Gastroenterol. 84:1989;133-137.
51. Megruad F. Diagnosis, and candidates for treatment of Helicobacter pylori infection. How should pylori infection be diagnosed? Gastroenterology. 113:1997;S93-S98.
52. El-Zimaity H.M.T., Segura A.M., Genta R.M., et al. Histologic assessment of Helicobacter pylori status after therapy Comparison of Giemsa, diff-quick, and Genta stains . Mod Pathol. 11:1998;288-291.
53. El-Zimaity H.M.T., Al-Assi M.T., Genta R.M., et al. Confirmation of successful therapy of Helicobacter pylori infection Number and sites of biopsies or a rapid urease test . Am J Gastroenterol. 90:1995;1962-1964.
54. Genta R.M., Huberman R.M., Graham D.Y. The gastric cardia in Helicobacter pylori infection. Hum Pathol. 25:1994;915-919.
55. Hazell S.L., Hennessy W.B., Borody T.J., et al. Campylobacter pylori gastritis II. Distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol. 82:1987;297-301.
56. Stolte M., Eidt S., Ohnsmann A. Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Z Gastroenterol. 28:1990;229-233.
57. Bayerdorffer E., Lehn N., Hatz R., et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology. 102:1992;1575-1582.
58. Graham D.Y., Karttunen T.J., Genta R.M. The evaluation of treatment of H. pylori infectious Strategies for the design of clinical trials . Endosc Dig. 6:1994;991-1006.
59. Kolts B.E., Joseph B., Achem S.R., et al. Helicobacter pylori detection. A quality and cost analysis. Am J Gastroenterol. 88:1993;650-655.
60. Laine L., Lewin D.N., Naritoku W., et al. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointest Endosc. 45:1997;463-467.
61. Thijs J.C., Zwet A.A., Thijs W.J., et al. Diagnostic tests for Helicobacter pylori A prospective evaluation of their accuracy, without selecting a single test as the gold standard . Am J Gastroenterol. 91:1996;2125-2129.
62. Vigneri S., Termini R., Scialabba A., et al. Omeprazole therapy modifies the gastric localization of Helicobacter pylori. Am J Gastroenterol. 86:1991;1276. (letter).
63. Logan R.P., Walker M.M., Misiewicz J.J., et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 36:1995;12-16.
64. Schenk B.E., Kuipers E.J., Klinkenberg-Knol, et al. Helicobacter pylori and the efficacy of omperazole therpay for gastroesophageal reflux disease. Am J Gastroenterol. 94:1999;884-887.
65. Goldblum J.R., Vicari J.J., Falk G.W., et al. Inflammation, and intestinal metaplasia of the gastric cardia. The role of gastroesophageal relfux and H. pylori. Gastroenterology. 114:1998;633-639.
66. Skinner D.B., Walther B.C., Riddell R.H., et al. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg. 198:1983;554-565.
67. Gray M.R., Donnelly R.J., Kingsnorth A.N. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut. 34:1993;727-731.
68. Iftikhar S.Y., James P.D., Steele R.J.C., et al. Length of Barrett's oesophagus An important factor in the development of dysplasia and adenocarcinoma . Gut. 33:1992;1155-1158.
69. Miros M., Kerlin P., Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut. 32:1991;1441-1446.
70. Weston A.P., Krmpotich P.T., Cherian R., et al. Prospective long-term endoscopic and histologic follow-up of short segment Barrett's esophagus Comparison to traditional long segment Barrett's esophagus . Am J Gastroenterol. 92:1997;407-413.
71. Clark G.W.B., Smyrk T.C., Burdiles P., et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg. 129:1994;609-614.
72. Smith R.R.L., Boitnott J.K., Hamilton S.R., et al. The spectrum of carcinoma arising in Barrett's esophagus. Am J Surg Pathol. 8:1984;563-573.
73. MacDonald W.C., MacDonald J.B. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer. 60:1987;1094-1098.
74. Hamilton S.R., Smith R.R.L., Cameron J.L. Prevalence and characteristics of Barrett Esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol. 19:1988;942-948.
75. Duhaylongsod F.G., Wolfe W.G. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg. 102:1991;36-42.
76. Thompson J.J., Zinsser K.R., Enterline H.T. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol. 14:1983;42-61.
77. Hansen S., Vollset S.E., Ardill J.E.S., et al. Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons. Gastroenterology. 112:1997;A575. (abstract).
78. Vicari J.J., Peek R.M., Falk G.W., et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 115:1998;50-57.
79. Riddell R.H. Early detection of neoplasia of the esophagus and gastroesophageal junction. Am J Gastroenterol. 91:1996;853-863.
80. Hassall E. Barrett's esophagus New definitions and approaches in children . J Ped Gastroenterol Nutr. 16:1993;345-364.
81. Levine D.S. Barrett's esophagus Genomic changes and the importance of p53 . Practical Gastroenterol. 19:1995;32B-32H.
82. Graham D.Y. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer A model . Gastroenterology. 113:1997;1983-1991.
83. Graham D.Y., Yamaoka Y. H. pylori and cagA Relationship with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications . Helicobacter. 3:(3):1998;145-151.
84. Stotle M., Stadelmann O., Bethke B., et al. Relationships between degree of Helicobacter pylori colonization and the degree and activity of gastritis, surface degeneration and mucus secretion. Z Gastroenterol. 33:1995;89-93.
85. Bercik P., Verdu E., Armstrong D. Reflux esophagitis and H. pylori. Gastroenterology. 113:1997;2020. (letter).
86. Labenz J., Malfertheiner P. Helicobacter pylori in gastrooesophageal reflux disease Causal agent, independent or protective factor? Gut. 41:1997;277-280.
87. Konturek P.C.H., Ernst H., Konturek S.J., et al. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut. 40:1997;463-469.
88. Sarosiek J., Feng T., McCallum R.W. The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat. Am J Med Sci. 302:1991;359-363.
89. Sarosiek J., Bilski J., Murty V.L.N., et al. Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucus coat. Biochem Biophys Res Commun. 152:1988;1421-1427.
90. Konturek P.K., Brzozowski T., Konturek S.J., et al. Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress induced gastric lesions. Gastroenterology. 99:1990;1607-1615.
91. Polk W.H., Dempsy P.J., Russel W.E., et al. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology. 102:1992;1467-1474.